Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine. [electronic resource]
- Gene therapy Aug 2015
- 628-35 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1476-5462
10.1038/gt.2015.35 doi
Animals Disease Models, Animal Drug Evaluation, Preclinical Genetic Vectors Leishmaniasis--immunology Mice, Inbred BALB C Rats, Wistar Vaccines, DNA--administration & dosage